Microbiologytoday

Total Page:16

File Type:pdf, Size:1020Kb

Microbiologytoday microbiologytoday vol34|nov07 quarterly magazine of the society for general microbiology cytokines interferon – the early days cytokines, receptors and virus infection treating fungal infections with interferon protection against TB interferon – where are we now? contents vol34(4) regular features 146 News 184 Gradline 194 Reviews 178 Meetings 188 Going public 199 Addresses 180 Schoolzone 192 Hot off the press other items 154 Microshorts 197 Member’s reports 176 Historical anecdotes 198 Obituary 196 Scottish Infection Research Network articles 156 Interferon: 168 Gamma interferon and the early days fungal infections Derek C. Burke Javier Capilla, Karl Clemons Crude systems and mechanical operations featured during & David Stevens the ‘steam age of virology’. As fungal infections become more frequent and diverse, cytokines may be used to enhance the activity of antifungal treatment. Viruses and interferon – 160 Gamma interferon – key, but 50 years on 172 not sufficient for protection Rick Randall & Steve Goodbourn against TB? We have learnt a lot since Isaacs and Lindenmann described ‘the interferon’ in 1957, but the story is not over. Hazel Dockrell Although it is a good indicator of TB vaccine immunogenicity, heterogeneity means there may not be an easy answer when 164 Chemokines, it comes to gamma interferon. receptors and virus 200 Comment: Microbiology – infection a degree of concern? Edward Wright Sue Assinder Chemokine receptors are sometimes hijacked Analysis of the SGM undergraduate prize scheme suggests by pathogens to gain entry to cells and initiate we should be wary, but not too concerned about the decline infection. of microbiology departments. Cover image Polarized light micrograph of crystals of human interferon. Phillip A. Harrington, Peter Arnold Inc. / Science Photo Library The views expressed Editor Dr Matt Hutchings––Editorial Board Dr Sue Assinder, Professor Iain Hagan, Professor Bert Rima––Managing Editor Janet Hurst––Assistant Editor Lucy Goodchild by contributors are not Design & Production Ian Atherton––Contributions are always welcome and should be addressed to the Editor c/o SGM Headquarters, Marlborough House, necessarily those of the Basingstoke Road, Spencers Wood, Reading RG7 1AG–Tel. 0118 988 1809–Fax 0118 988 5656–email [email protected]–web www.sgm.ac.uk–– Society; nor can the Advertising David Lancaster, Ten Alps Publishing, London Office, 10 Savoy Street, London WC2E 7HR–t 0207 878 2316–f 0207 379 7118–e [email protected] Regular feature images pp. 147 SGM; 179, 181, 195 Comstock / Jupiter Images; 185, 193 Stockbyte; 189, AbleStock / Jupiter Images; 199 Digital Vision / Getty claims of advertisers © 2007 The Society for General Microbiology––ISSN 1464-0570––Printed by Latimer Trend & Company Ltd, Plymouth, UK be guaranteed. news New category of membership for 2008 SGM Council June meeting That SGM is pleased to announce a new category of membership: Members will have the same benefits as before, such as SGM strategy longest Associate Membership. It embraces the former categories special concessions and grants for attending SGM meetings. Following up on earlier considerations of Strategy Group running of Technician, Postgraduate Student and Retired Membership, The annual subscription for Associate Membership is recommendations, Council discussed ways of networking experiment but aims to support a whole range of other microbiologists. only £25. All Associate Members will be eligible for special with other societies and scientific organizations. It was Associate Membership is also open to microbiologists discounted registration fees to attend SGM meetings and noted that the BBSRC Director of Research has approached again resident in the UK or Republic of Ireland employed receive Microbiology Today. Eligibility for grants remains the the society with a view to collaborating on setting up Imran Hayat really in universities, research institutes, hospitals/HPA or same as before – see www.sgm.ac.uk/grants to check out strategic networks, as recommended in the Dorman Review enjoyed reading Dr Jean commercial institutions, whose salaries are no higher than the schemes that apply to you. of Microbial Science. SGM has also been invited by Defra Lindenmann’s article in £25,000 p.a. gross. It is intended for graduate scientists, Existing Technician, Postgraduate Student and Retired to carry out an independent review of their research into the February issue of the research assistants, postdoctoral fellows, biomedical Members will be automatically converted to Associates, but bovine TB in the UK. magazine which has stirred scientists, clinical scientists, etc., as well as technicians. up some debate about the if you are an Ordinary Member and are eligible to change Council review Experts Postgraduate Student Associate Membership is still available to the Associate category, look out for the invoice to renew world’s longest running The internal review of the composition of Council, its to anyone registered for a microbiology higher degree your subscription which will be arriving any time now. This wanted! experiment. He agrees functions and workings as well as the responsibilities of worldwide, subject to the £25k salary cap. Retired Associate contains full details of what to do. with Richard Jackson that members of Council and roles of SGM officers, chaired by SGM needs the field experiments Petra Oyston, is ongoing. you! at Rothamsted are the All change for SGM meetings SGM membership SGM actively promotes longest running biological As a result of requests to alter the structure of SGM meetings and observations of changes Council approved a new category of membership, termed microbiology to the media experiments, but disagrees in the profile of subject areas within microbiology, Council held a full review of the entire ‘Associate Membership’. This will include recent graduates, and helps journalists obtain with Tim Mahony about the meetings system earlier this year. It was carried out by a small working party made up of postgraduate students, early career postdoctoral fellows, accurate information. claim about the pitch drop Council members, Group conveners and Marlborough House staff. The recommendations clinical trainees, technicians, biomedical scientists and To do this we need experiment in the Guinness were considered and endorsed with very minor changes by conveners in May and approved retired members (see p. 146 for details). scientists to answer their Book of Records! at June Council. questions. With so many Review of scientific meetings and group structure ‘There are a number of The existing group structure is to be replaced by five divisions (Prokaryotic microbiology, microbiological stories much older experiments, Hilary Lappin-Scott reported on the recommendations Eukaryotic microbiology, Virology, Education and Irish). Each scientific division will be in the press these days, my favourite being that agreed by a Working Party earlier this year. Radical changes divided into four themes (Microbial diversity and evolution; Fundamental microbiology; more experts are urgently of Lord Kelvin’s artificial are planned, including a new organizational structure Translational and applied microbiology; Infectious disease) to ensure that all areas of required to join our existing glacier experiment started for delivering the science and a different timetable for microbial science are covered. The programmes for SGM meetings will be devised through database of contacts. in 1887 which can still meetings. See p. 146 for details. The new system will be a matrix management system, starting with the 2009 spring meeting in Harrogate. Each Whether you have dealt be seen at the Hunterian phased in from September 2007 and take over in the spring division will be headed by a chair and chair-elect, who will sit on the Scientific Meetings with the media for years Museum at Glasgow of 2009. Council approved these proposals, thanked Hilary Committee responsible for making decisions on policy and meetings content. The Scientific or never spoken to a University. The world’s for chairing the review and welcomed her preparedness to Meetings Officer will have a deputy under the new system. SGM members will also be able journalist in your life, we longest running experiment serve for one more year beyond her term of office (until to propose sessions for consideration, via a form on the website. want to hear from you. We is the Oxford Electric Bell or September 2009) to see the changes through. can offer help with media Clarendon Dry Pile* at the There will still be two meetings a year, in spring and autumn, each lasting 3½ days, but training if necessary and we University of Oxford which the timetable of the meetings has been formalized. There will be up to four concurrent SGM journals always check first that you has rung continuously since symposia each morning and flexible sessions in the afternoons. These can be workshops, The Microbiology editorial office has made significant are willing to deal with an 1840. The experiment training courses, debates, offered papers, mini-symposia, etc. Poster viewing will now take progress in introducing the Bench>Press system for enquiry. was set up to determine place in the early evenings, with drinks. manuscript processing and journal production. It is hoped Everyone’s an expert or test the theory of We look forward to implementing this exciting new system which aims to provide balanced to complete the implementation of this system for all four in their own
Recommended publications
  • Of Animals, Nature and People.[Student's Guide.] Preparing
    DOCUMENT RESUME ED-23'0 377 SE 041 574 i . AUTHOR Iozzi, Louis A.; And Others TITLE Of Animals,-Nature and People. (S:udent's Guide.] Preparing for Tomorrow's World. 4 IN5TITUTION . Rutgers, The State Univ., New Brunswick, N.J. Center . for Coastal and Environmental Studies. SPONS AGENCY New Jersey State Dept. of Education, Trenton. PUB DATE 80 - , NOTE 132p.; For related documents, see SE 61 564-585. A complete catalog of the multi-media packages making , up this program is contained in,SE 041 585. , AVAILABLE FROMSOPRIS WEST, Inc., 1120 Delaware Ave., Longmont, CO . 80501 (Complete multi-media module, including stddent materials, $95; replacement student worksheets, $2). PUB TYPE Guides- Classroom Use -,Materials (For Learner) (051) EDRS PRICE MF01 Plus Postage. PC Not Available froM'EDRS. DESCRIPTORS Animals; Critical ThinkingrDecision Making; *Environmental Education; *Futures (of Society); High Schools; Interdisciplinary Approach; Learning Activities;. Moral Development; *Moral Issues; *tatural Resources; Physical Environffient; *Problem Solving; Role Plaking; Science Education; Secondary SChool Science; Social Studies; Student'Attitudes; Technology; Wildlife IDENTIFIERS. Dilemma Discussion Approach; *Environmental Ethic; . Preparing for Tomorrows'World PrograM; *Science and Society ABSTRACT Developing an awareness of the need to evolim an environmental ethic is the intent of this module, designed for the . senior high school level (grades 10-11)% The module is divided into two sections. Section 1 contains a series of dilemma/discussion activities raising issues regarding hulnan behavior toward, animals and the natural environment. Dilemmas.are-brief stories posing a critical decision to be made by a mainscharacter: This decision.revolves aroUnd conflicts between two .or more moral/ethical'isstes (as .
    [Show full text]
  • Advancing Tuberculosis Vaccines from Discovery to Clinical Development
    Research Collection Review Article TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development Author(s): Kaufmann, Stefan H.E.; Dockrell, Hazel M.; Drager, Nick; Ho, Mei M.; McShane, Helen; Neyrolles, Olivier; Ottenhoff, Tom H.M.; Patel, Brij; Roordink, Danielle; Spertini, François; Stenger, Steffen; Thole, Jelle; Verreck, Frank A.W.; Williams, Ann; TBVAC2020 Consortium Publication Date: 2017-10-04 Permanent Link: https://doi.org/10.3929/ethz-b-000197748 Originally published in: Frontiers in Immunology 8, http://doi.org/10.3389/fimmu.2017.01203 Rights / License: Creative Commons Attribution 4.0 International This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library REVIEW published: 04 October 2017 doi: 10.3389/fimmu.2017.01203 TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development Stefan H. E. Kaufmann1*, Hazel M. Dockrell 2, Nick Drager 3, Mei Mei Ho4, Helen McShane5, Olivier Neyrolles 6, Tom H. M. Ottenhoff 7, Brij Patel 8, Danielle Roordink3, François Spertini 9, Steffen Stenger10, Jelle Thole3, Frank A. W. Verreck11, Ann Williams12 and TBVAC2020 Consortium 1 Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany, 2 Immunology and Infection Department, London School of Hygiene and Tropical Medicine, London, United Kingdom, 3 Tuberculosis Vaccine Initiative (TBVI), Lelystad, Netherlands, 4 Bacteriology Division, MHRA-NIBSC, Potters Bar, United Kingdom,
    [Show full text]
  • And Ludwik Rajchman (1881-1965)
    Macfadyen, David (2014) The genealogy of WHO and UNICEF and the intersecting careers of Melville Mackenzie (1889-1972) and Ludwik Rajchman (1881-1965). MD thesis. http://theses.gla.ac.uk/5625/ Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] The Genealogy of WHO and UNICEF and the Intersecting Careers of Melville Mackenzie (1889-1972) and Ludwik Rajchman (1881-1965) David Macfadyen MB ChB (Glasg), MSc (London), FRCP Edin. A thesis submitted to the University of Glasgow for the degree of Doctor of Medicine Centre for the History of Medicine College of Medical, Veterinary and Life Sciences University of Glasgow September 2014 Page 1 of 323 Summary This thesis traces the antecedents of the World Health Organization (WHO) back to 1920, when a new type of international health organization emerged following the establishment of the League of Nations, one that was based on collective action by nation-states. The 1946 Constitution of WHO specifies two prime functions for the Organization – technical assistance to countries and cooperation with governments to strengthen national health services.
    [Show full text]
  • Reassessing Twenty Years of Vaccine Development Against Tuberculosis Edited by : Ulrich E
    REASSESSING TWENTY YEARS OF VACCINE DEVELOPMENT AGAINST TUBERCULOSIS EDITED BY : Ulrich E. Schaible and Stefan H. Kaufmann PUBLISHED IN : Frontiers in Immunology Frontiers Copyright Statement About Frontiers © Copyright 2007-2018 Frontiers Media SA. All rights reserved. Frontiers is more than just an open-access publisher of scholarly articles: it is a pioneering All content included on this site, approach to the world of academia, radically improving the way scholarly research such as text, graphics, logos, button icons, images, video/audio clips, is managed. The grand vision of Frontiers is a world where all people have an equal downloads, data compilations and software, is the property of or is opportunity to seek, share and generate knowledge. Frontiers provides immediate and licensed to Frontiers Media SA permanent online open access to all its publications, but this alone is not enough to (“Frontiers”) or its licensees and/or subcontractors. The copyright in the realize our grand goals. text of individual articles is the property of their respective authors, subject to a license granted to Frontiers. Frontiers Journal Series The compilation of articles constituting The Frontiers Journal Series is a multi-tier and interdisciplinary set of open-access, online this e-book, wherever published, as well as the compilation of all other journals, promising a paradigm shift from the current review, selection and dissemination content on this site, is the exclusive property of Frontiers. For the processes in academic publishing. All Frontiers journals are driven by researchers for conditions for downloading and researchers; therefore, they constitute a service to the scholarly community. At the same copying of e-books from Frontiers’ website, please see the Terms for time, the Frontiers Journal Series operates on a revolutionary invention, the tiered publishing Website Use.
    [Show full text]
  • Curriculum Vitae
    Biodata: Professor Rabia Hussain ( email: [email protected]) EDUCATION 1966 B.Sc (Hon). Karachi University. Division 1 Position 1 (summa cum laude) Subjects: Microbiology, Biochemistry and Botany. (summa cum laude) 1967 M.Sc. Karachi University, Division 1, Position Subject : Microbiology 1973 PhD, University of Western Ontario Canada, Subject: Immunology Thesis Titles 1968. M.Sc. Thesis: Cross reactions of avian and mammalian gamma globulins, Karachi University, Pakistan 1973. PhD Thesis: Isolation, purification and characterization of an Ascaris suum allergen, University of Western Ontario, Canada. PROFESSIONAL QUALIFICATIONS 1989 : MRC Path: London, U.K. Subject: Immunology 1997 : FRC Path: London, U.K. Subject: Immunology. BRIEF CHRONOLOGY OF EMPLOYMENT 1968-69 Assistant Lecturer, Department of Microbiology, University of Karachi, Karachi, Pakistan 1970-72 Teaching Assistant, Department of Bacteriology and Immunology University of Western Ontario, Canada 1973-75 Research Associate, National Research Council (USA) Naval Medical Research Institute, National Naval Medical Center. 1976-79 Instructor, Department of Medicine, John Hopkins University, USA 1979-81 Collaborative Researcher, National Institutes of Health, National Institutes of Allergy and Infectious Diseases. USA 1981-85 Senior Staff Fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. 1985-90 Associate Professor, Department of Microbiology The Aga Khan University, Karachi, Pakistan Jan - March 2005 2 Acting Chairperson,
    [Show full text]
  • Towards Correlates of Protection for Tuberculosis
    Developments in new TB biomarkers Hazel M Dockrell London School of Hygiene & Tropical Medicine [email protected] - Why do we need biomarkers so badly? - Biomarkers of vaccine immunogenicity - Biomarkers for (early) diagnosis - Correlates of protection - New developments in TB biomarkers - Biomarkers in TBVAC2020 Global pipeline of TB vaccine candidates Foundation to facilitate European efforts Foundation to facilitate European efforts towardstowards the the global global development development of new of new TBTB vaccines vaccines 5www.tbvi.eu March 2008 How can we select better candidates? shifting the risk curve . discovery preclinical Phase I Phase II Phase III RISK prediction of likely efficacy in preclinical plus early human trials assessment of efficacy in Phase IIB clinical trial MONEY Biomarkers of immunogenicity following vaccination Immunogenicity of BCG in UK infants: IFNg UNVAC BCG VAC 1 1 n=51 n=36 .8 .8 .6 .6 proportion .4 proportion .4 .2 .2 0 0 0 31 62 125 250 500 1000 2000 4000 8000 0 31 62 125 250 500 1000 2000 4000 8000 IFN-g response (pg/ml) IFN-g response (pg/ml) • 3 months after BCG vaccination at 3-13 weeks of age, 100% of the UK infants given BCG vaccination made IFNg responses >62pg/ml to PPD; none of the unvaccinated infants were IFNg responders (Lalor et al JID 2009, 199:795) TBVAC-associated sub-unit TB vaccines: MVA85A Phase 1 –trial in Immunogenicity: PPD neg excellent primary response MVA85A alone or Safety: low reactogenicity BCG + MVA85A 750 IFNg-ELISPOT 500 PBMC 6 MVA85A BCG + MVA85A 250 SFC/1x10
    [Show full text]
  • Ion Gresser 1928–2019
    obituary Ion Gresser 1928–2019 on Gresser, a virologist who transformed of another interferon pathfinder, Charles understanding of the roles of interferons, Chany, at the Hôpital St. Vincent de Paul, Imay be best remembered for showing and soon thereafter establishing his own that in mice, interferon-α (IFN-α) can laboratory at the Institut de Recherches produce acute and chronic disease. At the Scientifiques sur le Cancer in Villejuif, time Gresser began these studies, interferon outside Paris. Eventually, Gresser ended up was considered to be a selective antiviral spending decades at the Villejuif laboratory, substance, harmless to uninfected cells and and it was there that he conducted all of organisms, and there was no indication that his many original studies for which he cytokines would play a role in pathogenesis. became known. Although he retired from That belief was shattered with the 1975 his position at Villejuif many years ago, Nature publication with the simple title he continued to publish reviews, as well “Lethality of interferon preparations for as original research in collaboration with newborn mice.” others. His very last paper, co-authored with Gresser subsequently demonstrated Pierre Lebon, Yanick Crow and Jean-Laurent that antibodies to IFN-α can protect young More surprising at the time was the first Casanova, appeared in March of this year, mice from death caused by infection with demonstration, by Gresser and colleagues only weeks before his passing. lymphocytic choriomeningitis virus. This in 1973, that IFN-α enhances the expression Arguably, the most important study can be considered a stepping-stone of histocompatibility antigens and modifies contribution of Gresser and his colleagues for the therapeutic application of antibodies the surface of uninfected cells, and that was the demonstration of harmful effects to cytokines in the treatment of human it has other immunomodulatory actions.
    [Show full text]
  • Human Genetic Basis of Interindividual Variability in the Course of Infection
    Human genetic basis of interindividual variability in the course of infection Jean-Laurent Casanovaa,b,c,d,e,1 aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bHoward Hughes Medical Institute, New York, NY 10065; cLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, 75015 Paris, France; dImagine Institute, Paris Descartes University, 75015 Paris, France; and ePediatric Hematology and Immunology Unit, Assistance Publique–Hôpitaux de Paris, Necker Hospital for Sick Children, 75015 Paris, France This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2015. Contributed by Jean-Laurent Casanova, November 2, 2015 (sent for review September 15, 2015; reviewed by Max D. Cooper and Richard A. Gatti) The key problem in human infectious diseases was posed at the immunity (cell-autonomous mechanisms), then of cell-extrinsic turn of the 20th century: their pathogenesis. For almost any given innate immunity (phagocytosis of pathogens by professional cells), virus, bacterium, fungus, or parasite, life-threatening clinical disease and, finally, of cell-extrinsic adaptive immunity (somatic di- develops in only a small minority of infected individuals. Solving this versification of antigen-specific cells). Understanding the patho- infection enigma is important clinically, for diagnosis, prognosis, genesis of infectious diseases, particularly
    [Show full text]
  • TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
    REVIEW published: 04 October 2017 doi: 10.3389/fimmu.2017.01203 TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development Stefan H. E. Kaufmann1*, Hazel M. Dockrell 2, Nick Drager 3, Mei Mei Ho4, Helen McShane5, Olivier Neyrolles 6, Tom H. M. Ottenhoff 7, Brij Patel 8, Danielle Roordink3, François Spertini 9, Steffen Stenger10, Jelle Thole3, Frank A. W. Verreck11, Ann Williams12 and TBVAC2020 Consortium 1 Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany, 2 Immunology and Infection Department, London School of Hygiene and Tropical Medicine, London, United Kingdom, 3 Tuberculosis Vaccine Initiative (TBVI), Lelystad, Netherlands, 4 Bacteriology Division, MHRA-NIBSC, Potters Bar, United Kingdom, 5 University of Oxford, Oxford, United Kingdom, 6 Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France, 7 Leiden University Medical Center, Leiden, Netherlands, 8 RegExcel Consulting Ltd, Surrey, United Kingdom, 9 Centre Hospital Universitaire Vaudois, Lausanne, Switzerland, 10 University Hospital of Ulm, Ulm, Germany, Edited by: 11 Biomedical Primate Research Centre, Rijswijk, Netherlands, 12 Public Health England, London, United Kingdom Kuldeep Dhama, Indian Veterinary Research Institute (IVRI), India TBVAC2020 is a research project supported by the Horizon 2020 program of the Reviewed by: European Commission (EC). It aims at the discovery and development of novel tuber- Adel M. Talaat, University of Wisconsin-Madison, culosis (TB) vaccines from preclinical research projects to early clinical assessment. The United States project builds on previous collaborations from 1998 onwards funded through the EC Shoor Vir Singh, framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners Central Institute for Research on Goats (ICAR), India from outstanding laboratories from all over the world, now totaling 40 institutions.
    [Show full text]
  • Secreting CD8 T Lymphocytes Specific for Mycobacterium
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 270–275, January 1998 Immunology Human cytolytic and interferon g-secreting CD81 T lymphocytes specific for Mycobacterium tuberculosis i AJIT LALVANI*†,ROGER BROOKES*†‡,ROBERT J. WILKINSON§¶,ADAM S. MALIN ,ANSAR A. PATHAN*, i PETER ANDERSEN**, HAZEL DOCKRELL ,GEOFFREY PASVOL¶, AND ADRIAN V. S. HILL* *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom; §Tuberculosis and Related Infections Unit, Royal Postgraduate Medical School, London W12 0NN, United Kingdom; ¶Department of Infection and Tropical Medicine, Imperial College School of Medicine, Northwick Park Hospital, London HA1 3UJ, United Kingdom; iClinical Sciences, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E, United Kingdom; and **Tuberculosis Unit, Staatens Seruminstitut, Artileriweg 5, Copenhagen-S, Denmark DK2300 Edited by Barry R. Bloom, Albert Einstein College of Medicine, Hasting-on-Hudson, NY, and approved October 28, 1997 (received for review July 11, 1997) ABSTRACT Protective immunity to Mycobacterium tuber- Two secreted antigens of M. tuberculosis, early secretory culosis is poorly understood, but mounting evidence, at least in antigenic target 6 (ESAT-6) and the Antigen 85 complex, were animal models, implicates major histocompatibility complex studied because secreted antigens are implicated as targets of class I-restricted CD81 T cells as an essential component. By protective immune responses (8) and are more likely to access using a highly sensitive assay for single cell interferon g the host cell cytosol and hence the MHC class I antigen release, we screened an array of M. tuberculosis antigen- processing pathway.
    [Show full text]
  • Kaufmann, Stefan H. E. and Dockrell, Hazel M. and Drager, Nick and Ho, Mei Mei and Mcshane, Helen and Neyrolles, Olivier and Ottenhoff, Tom H
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Strathclyde Institutional Repository Kaufmann, Stefan H. E. and Dockrell, Hazel M. and Drager, Nick and Ho, Mei Mei and McShane, Helen and Neyrolles, Olivier and Ottenhoff, Tom H. M. and Patel, Brij and Roordink, Danielle and Spertini, François and Stenger, Steffen and Thole, Jelle and Verreck, Frank A. W. and Williams, Ann and Britton, Warwick and Triccas, Jamie and Counoupas, Claudio and Grooten, Johan and Marie-Ange Demoitie, Demoitie and Romano, Marta and Huygen, Kris and Tima, Hermann Giresse and Mascart, Francoise and Andersen, Peter and Aagaard, Claus and Christensen, Dennis and Ruhwald, Morten and Lindenstrom, Thomas and Charneau, Pierre and Guilhot, Christophe and Peixoto, Antonio and Gilleron, Martine and Vergne, Isabelle and Locht, Camille and Brosch, Roland and Inchauspe, Genevieve and Theung Long, Stephane Leung and Weiner, January and Maertzdorf, Jeroen and Nieuwenhuizen, Natalie and Bastian, Max and Kallert, Stephanie and Gordon, Stephen and Caccamo, Nadia and Goletti, Delia and Nisini, Roberto and Shin, Sung Jae and Cho, Sang Nae and Lee, Hyejon and Choi, Ino and Sigal, Alex and Scriba, Thomas and Walzl, Gerhard and Loxton, Andre and Wilkinson, Robert and Wilkinson, Katalin and Cardona, Pere Joan and Vilaplana, Cris and Martin, Carlos and Marinova, Dessi and Aguilo, Nacho and Aebersold, Ruedi and Caron, Etienne and Pinschewer, Daniel and De Libero, Gennaro and Siegrist, Claire Anne and Collin, Nicolas and Barnier-Quer,
    [Show full text]
  • Richardus, JH; Ideal Consortium, (2005)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by LSHTM Research Online Aseffa, A; Brennan, P; Dockrell, H; Gillis, T; Hussain, R; Oskam, L; Richardus, JH; Ideal Consortium, (2005) Report on the First Meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium held at Armauer Hansen Research Institute, ALERT, Addis Ababa, Ethiopia on 24-27 October 2004. Leprosy re- view, 76 (2). pp. 147-59. ISSN 0305-7518 Downloaded from: http://researchonline.lshtm.ac.uk/12081/ DOI: Usage Guidelines Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna- tively contact [email protected]. Available under license: Copyright the publishers Lepr Rev (2005) 76, 147–159 SPECIAL PAPER Report on the First Meeting of the IDEAL (Initia- tive for Diagnostic and Epidemiological Assays for Leprosy) Consortium held at Armauer Hansen Research Institute, ALERT, Addis Ababa, Ethiopia on 24–27 October 2004 ABRAHAM ASEFFA, PATRICK BRENNAN, HAZEL DOCKRELL, TOM GILLIS, RABIA HUSSAIN, LINDA OSKAM & JAN HENDRIK RICHARDUS ON BEHALF OF THE IDEAL CONSORTIUM Accepted for publication 18 February 2005 Introduction The IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium was established following a WHO/TDR sponsored workshop held in Amsterdam in October 2003, in which strategies for the development of new diagnostic and epidemiological assays, based on these technical developments, were defined. An Interim Steering Committee was appointed with the objective to set up a network of relevant research and field sites, write a coordinated research proposal and, where possible, coordinate activities between partners.
    [Show full text]